Result:Poor· Market: Crashed
| Metric | Value (₹ Cr) | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue | 0.00 | ||
| Total Income | 0.00 | 98.6% | |
| Expenditure | 0.26 | 50.5% | 124.1% |
| PBT | -0.26 | 47.2% | 123.7% |
| Net Profit | -0.26 | 47.2% | 123.7% |
| OPM | — | ||
| NPM | — | ||
| EPS | 0.06 | 83.8% | 33.3% |
Pharma company reported zero revenue and a widening net loss YoY (-123.7%), with no core business activity to support quality.
Informational and educational content only. Not investment advice.